J. Y. Park

502 total citations
6 papers, 377 citations indexed

About

J. Y. Park is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, J. Y. Park has authored 6 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in J. Y. Park's work include Peptidase Inhibition and Analysis (2 papers), Diabetes Treatment and Management (2 papers) and Pancreatic function and diabetes (2 papers). J. Y. Park is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Diabetes Treatment and Management (2 papers) and Pancreatic function and diabetes (2 papers). J. Y. Park collaborates with scholars based in South Korea, United States and India. J. Y. Park's co-authors include Kyong Soo Park, K.-U. Lee, H. K. Lee, Hyoung Doo Shin, Jason H. Moore, Marylyn D. Ritchie, Young‐Man Cho, Kenneth B. Pomerantz, Dong Seop Choi and Chankyu Park and has published in prestigious journals such as Diabetologia, Diabetic Medicine and Diabetes Obesity and Metabolism.

In The Last Decade

J. Y. Park

6 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Y. Park South Korea	6	168	146	86	83	50	6	377
Matilde Marchetta Italy	8	112 0.7×	82 0.6×	104 1.2×	52 0.6×	36 0.7×	9	346
Massimo Realacci Italy	11	69 0.4×	57 0.4×	66 0.8×	23 0.3×	80 1.6×	17	321
María Luisa Ordóñez-Sánchez Mexico	11	142 0.8×	201 1.4×	153 1.8×	13 0.2×	140 2.8×	18	426
Takehiko Tominaga Japan	4	188 1.1×	73 0.5×	29 0.3×	61 0.7×	44 0.9×	7	398
Hajime Ueshiba Japan	12	275 1.6×	162 1.1×	72 0.8×	6 0.1×	83 1.7×	27	445
Mohammad Al-Haggar Egypt	11	17 0.1×	87 0.6×	53 0.6×	29 0.3×	38 0.8×	47	330
Han Wook Yoo South Korea	10	77 0.5×	116 0.8×	87 1.0×	4 0.0×	67 1.3×	50	416
Xinwang Zhu China	12	30 0.2×	247 1.7×	23 0.3×	11 0.1×	33 0.7×	21	453
Emma T. B. Olesen Denmark	11	73 0.4×	411 2.8×	48 0.6×	18 0.2×	50 1.0×	13	550
J T Clarkson United States	11	360 2.1×	253 1.7×	71 0.8×	8 0.1×	32 0.6×	12	528

Countries citing papers authored by J. Y. Park

Since Specialization

Citations

This map shows the geographic impact of J. Y. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Y. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Y. Park more than expected).

Fields of papers citing papers by J. Y. Park

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Y. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Y. Park. The network helps show where J. Y. Park may publish in the future.

Co-authorship network of co-authors of J. Y. Park

This figure shows the co-authorship network connecting the top 25 collaborators of J. Y. Park. A scholar is included among the top collaborators of J. Y. Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Y. Park. J. Y. Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Yang, Sae Jeong, Sandeep K. Gupta, J. Y. Park, et al.. (2012). A multicentre, multinational, randomized, placebo‐controlled, double‐blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin ( LC15 ‐0444) in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 15(5). 410–416. 41 indexed citations

2.

Rhee, Eun‐Jung, Won‐Young Lee, Kun‐Ho Yoon, et al.. (2010). A multicenter, randomized, placebo‐controlled, double‐blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15‐0444 in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 12(12). 1113–1119. 37 indexed citations

3.

Cho, N. H., Chul Woo Ahn, J. Y. Park, et al.. (2005). Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus. Diabetic Medicine. 23(2). 198–203. 88 indexed citations

4.

Cho, Young‐Man, Marylyn D. Ritchie, Jason H. Moore, et al.. (2004). Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus. Diabetologia. 47(3). 549–554. 151 indexed citations

5.

Ahn, Jung‐Mo, et al.. (2001). Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia. 44(6). 713–720. 44 indexed citations

6.

Lee, Wookjin, Jerry P. Palmer, Kyong Soo Park, et al.. (2001). Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical Type I diabetes. Diabetologia. 44(12). 2187–2191. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact